Case Report of a Kidney Transplant Recipient Converted to Everolimus Due to Malignancy: Resolution of Bronchiolitis Obliterans Organizing Pneumonia Without Everolimus Discontinuation

Agrahakar, 2004, Risk of malignancy with long-term immunosuppression in renal transplant recipients, Kidney Int, 66, 383, 10.1111/j.1523-1755.2004.00741.x Andres, 2005, Cancer incidence after immunosuppressive treatment following kidney transplantation, Crit Rev Oncol Hematol, 56, 71, 10.1016/j.critrevonc.2004.11.010 Campistol, 2006, Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation, J Am Soc Nephrol, 17, 581, 10.1681/ASN.2005090993 Stallone, 2005, Sirolimus for Kaposi’s sarcoma in renal-transplant recipients, N Engl J Med, 352, 1517, 10.1056/NEJMoa042831 Nuovo, 2000, The role of human papillomavirus in gynecological diseases, Crit Rev Clin Lab Sci, 37, 183, 10.1080/10408360091174204 Yee, 2006, Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies, Clin Cancer Res, 12, 5165, 10.1158/1078-0432.CCR-06-0764 Lane, 2006, Future directions in the treatment of hormone sensitive advanced breast cancer: the RAD 001 (everolimus)-letrozole clinical program, Semin Oncol, 33, S18, 10.1053/j.seminoncol.2006.03.024 Khariwala, 2006, Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII), Laryngoscope, 116, 814, 10.1097/01.mlg.0000210544.64659.35 Lebbé, 2006, Sirolimus conversion for patients with Kaposi sarcoma, Am J Transplant, 6, 2164, 10.1111/j.1600-6143.2006.01412.x Haydar, 2004, Sirolimus induced pneumonitis: three cases and a review of the literature, Am J Transplant, 4, 137, 10.1046/j.1600-6135.2003.00292.x